The Enterprise Value as of September 2024 (TTM) for Seagen Inc. (SGEN) is 42.84B

According to Seagen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 42.84B. This represents a change of 25.34% compared to the average of 34.18B of the last 4 quarters.

Seagen Inc. (SGEN) Historical Enterprise Value (quarterly & annually)

How has SGEN Enterprise Value performed in the past?

The mean historical Enterprise Value of Seagen Inc. over the last ten years is 13.94B. The current 42.84B Enterprise Value has changed 30.62% with respect to the historical average. Over the past ten years (40 quarters), SGEN's Enterprise Value was at its highest in in the September 2023 quarter at 39.60B. The Enterprise Value was at its lowest in in the December 2014 quarter at 3.92B.

Seagen Inc. (SGEN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Seagen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Seagen Inc. (SGEN) Average Enterprise Value

How has SGEN Enterprise Value performed in the past?

The current Enterprise Value of Seagen Inc. (SGEN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Seagen Inc. (SGEN) Enterprise Value vs. Peers

How is SGEN’s Enterprise Value compared to its peers?

Seagen Inc.’s Enterprise Value is greater than BioMarin Pharmaceutical Inc. (16.13B), greater than Alnylam Pharmaceuticals, Inc. (33.42B), greater than Exelixis, Inc. (7.21B), greater than Halozyme Therapeutics, Inc. (8.85B), greater than Legend Biotech Corporation (10.04B), greater than Zai Lab Limited (1.32B), greater than Ascendis Pharma A/S (6.58B), greater than Incyte Corporation (10.85B), greater than United Therapeutics Corporation (14.52B), greater than Ultragenyx Pharmaceutical Inc. (5.53B), greater than Apellis Pharmaceuticals, Inc. (5.11B), greater than Viking Therapeutics, Inc. (5.95B), greater than TG Therapeutics, Inc. (3.44B), greater than X4 Pharmaceuticals, Inc. (40.79M), greater than PDS Biotechnology Corporation (74.53M), greater than Madrigal Pharmaceuticals, Inc. (4.91B), greater than IVERIC bio, Inc. (5.14B), greater than Immunovant, Inc. (4.42B), greater than Akero Therapeutics, Inc. (1.56B),

Build a custom stock screener for Seagen Inc. (SGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seagen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seagen Inc. (SGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seagen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.